A5064608860- Pharmaceutical Practices and Patient Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Blood Pressure and Hypertension Studies
- Schizophrenia research and treatment
- Medication Adherence and Compliance
- Pharmacogenetics and Drug Metabolism
- Dementia and Cognitive Impairment Research
- Pharmacy and Medical Practices
- Patient Safety and Medication Errors
- Pharmaceutical Economics and Policy
- Drug-Induced Hepatotoxicity and Protection
- Computational Drug Discovery Methods
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health and Well-being Studies
- Intensive Care Unit Cognitive Disorders
- Anesthesia and Sedative Agents
- Geriatric Care and Nursing Homes
- HIV/AIDS Research and Interventions
- Healthcare professionals’ stress and burnout
- Mosquito-borne diseases and control
- Perfectionism, Procrastination, Anxiety Studies
- Reproductive tract infections research
- Vector-borne infectious diseases
- Chronic Disease Management Strategies
- Pharmacovigilance and Adverse Drug Reactions
Nova Scotia Health Authority
2017-2025
Dalhousie University
2014-2025
McMaster University
2025
Health Canada
2025
Digital Research Alliance of Canada
2022
-
Pharmacy professionals report experiencing burnout and stress in the workplace. Concerns exist that pharmacy profession are having an impact on patient care may be affecting sustainability of profession. In response, regulatory authorities worldwide exploring how to address workplace wellness. Jurisdictions have varied terms approaches taken, which range from surveys professionals, formation committees or working groups, legislative changes. The approach taken by New Brunswick College...
Abstract Background Prescribing cascades are a source of inappropriate prescribing for older adults with dementia. We aimed to study three in Nova Scotians dementia using administrative databases. Methods Cohort entry Scotia Seniors’ Pharmacare Program beneficiaries was the date diagnosis. Prescription drug dispensing data extracted inciting medication and second treatment (cholinesterase inhibitor bladder anticholinergic, metoclopramide Parkinson’s disease medication, or calcium channel...
Pharmacists in Nova Scotia have had legislated authority to prescribe since 2011. This study aimed describe the prescribing activities of pharmacists and characteristics patients who used pharmacist services.
ABSTRACT Lecanemab and donanemab are monoclonal antibody therapies that remove amyloid-beta from the brain. They first alter a fundamental mechanism, deposition, in Alzheimer disease (AD). To inform Canadian decisions on approval use of these drugs, Consortium Neurodegeneration Aging commissioned Work Groups to review evidence efficacy, safety new therapies, as well their projected impacts dementia systems care. We included persons with lived experience discussion about benefits harms. Our...
Despite well-established concerns regarding adverse drug effects, antipsychotics are frequently prescribed for older adults. Our first objective was to identify trends in antipsychotic dispensations Nova Scotians. STOPP (Screening Tool of Older Persons' Potentially Inappropriate Prescriptions) criteria use those with a history falls as potentially inappropriate. second trends, predictors, and adherence this by identifying continued following fall-related hospitalization.A descriptive...
Older adults living with dementia may express challenging responsive behaviours. One management strategy is pharmacologic treatment though these options often have limited benefit, which lead to multiple treatments being prescribed.The aim of the present study was describe psychoactive medication polypharmacy and explore factors associated in a cohort older Nova Scotia, Canada, including gender-stratified analysis. This retrospective those aged 65 years or recorded diagnosis between 2005...
Introduction: Prescribing cascade refers to use of a medication treat drug-related adverse event. cascades increase use, cost, and risk events. Objective: Our objective was administrative health data identify whether medications from the anticholinergic cognitive burden scale associated with proton pump inhibitor (PPI) prescribing consistent in older adults dementia. Method: The cohort comprised Nova Scotia Seniors’ Pharmacare beneficiaries identified have dementia dispensation recorded...
Introduction : Deprescribing is a complex process involving patients and healthcare providers. The aim of the project was to examine learning needs preferences providers students inform development an interprofessional deprescribing education program. Methods An online survey pharmacists, nurses, nurse practitioners, family physicians, associated practicing or studying in Nova Scotia conducted. Respondents were recruited by purposive snowball sampling have at least five respondents within...
<h3>Context:</h3> Few studies have looked at polypharmacy and frequently used medications in the last months of life persons with dementia (PWD), where benefits some are uncertain. We still do not know to which extent medication differs between PWD without (PWOD) near end life. <h3>Objective:</h3> To describe prevalence 90 days before death PWOD. <h3>Study Design:</h3> Repeated yearly cohort study from 2007 2022. <h3>Dataset:</h3> Provincial database linking 5 Quebec health administrative...
Background: Lyme disease is a bacterial infection transmitted to humans through bites from infected Ixodes species of ticks. Prophylaxis with single dose oral doxycycline following bite an tick reduces the risk developing disease. Pharmacists in Nova Scotia (NS) were among first Canada prescribe for this indication. The primary objective study describe experiences pharmacist prescribing prophylaxis after NS. Methods: A retrospective cohort was performed using health administrative data 16...